Equity Overview
Price & Market Data
Price: $0.451
Daily Change: +$0.0114 / 2.53%
Range: $0.42 - $0.48
Market Cap: $4,753,452
Volume: 310,481
Performance Metrics
1 Week: 20.00%
1 Month: -28.49%
3 Months: -94.65%
6 Months: -99.37%
1 Year: -99.86%
YTD: -98.77%
Company Details
Employees: 5
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California.